Zura Bio Statistics
Total Valuation
Zura Bio has a market cap or net worth of $222.48 million. The enterprise value is $132.66 million.
Market Cap | 222.48M |
Enterprise Value | 132.66M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Zura Bio has 63.75 million shares outstanding. The number of shares has increased by 1,220.83% in one year.
Shares Outstanding | 63.75M |
Shares Change (YoY) | +1,220.83% |
Shares Change (QoQ) | +41.89% |
Owned by Insiders (%) | 39.15% |
Owned by Institutions (%) | 49.93% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 3.65 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.17, with zero debt.
Current Ratio | 6.17 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -95.30% and return on invested capital (ROIC) is -103.75%.
Return on Equity (ROE) | -95.30% |
Return on Assets (ROA) | -58.80% |
Return on Capital (ROIC) | -103.75% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.01M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.36% in the last 52 weeks. The beta is 0.25, so Zura Bio's price volatility has been lower than the market average.
Beta (5Y) | 0.25 |
52-Week Price Change | -47.36% |
50-Day Moving Average | 4.26 |
200-Day Moving Average | 4.16 |
Relative Strength Index (RSI) | 42.42 |
Average Volume (20 Days) | 339,150 |
Short Selling Information
The latest short interest is 710,068, so 1.11% of the outstanding shares have been sold short.
Short Interest | 710,068 |
Short Previous Month | 643,377 |
Short % of Shares Out | 1.11% |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.05 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -63.30M |
Pretax Income | -58.52M |
Net Income | -60.18M |
EBITDA | -58.52M |
EBIT | -58.52M |
Earnings Per Share (EPS) | -$1.38 |
Balance Sheet
The company has $89.82 million in cash and no debt, giving a net cash position of $89.82 million or $1.41 per share.
Cash & Cash Equivalents | 89.82M |
Total Debt | n/a |
Net Cash | 89.82M |
Net Cash Per Share | $1.41 |
Equity (Book Value) | 61.01M |
Book Value Per Share | 0.96 |
Working Capital | 75.80M |
Cash Flow
In the last 12 months, operating cash flow was -$16.78 million and capital expenditures -$7,000, giving a free cash flow of -$16.79 million.
Operating Cash Flow | -16.78M |
Capital Expenditures | -7,000 |
Free Cash Flow | -16.79M |
FCF Per Share | -$0.36 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Zura Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1,220.83% |
Shareholder Yield | -1,220.83% |
Earnings Yield | -27.05% |
FCF Yield | -7.55% |
Analyst Forecast
The average price target for Zura Bio is $19.20, which is 450.14% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $19.20 |
Price Target Difference | 450.14% |
Analyst Consensus | Strong Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |